The Latest Research in Stem Cell Therapies
Photo Credit: Asymmetrex
Research on Muscular Dystrophy is a dynamic field and since the 1980's there have been major advancements.
Here you will find the latests research on stem cell therapies that show real promise for Duchenne.
New Research in Stem Cells
Ottowa researchers discover various pharmaceutical components may have the ability to improve the myogenic potential of dystrophin-deficient satellite cells. "A combined therapeutic approach that improves satellite cell function in DMD patients could transform this severely debilitating disease into a manageable chronic condition."
Researchers using the gene-editing technique CRISP demonstrated the ability to "cut out" faulty gene sequences in mice, effectively restoring dystophin production in the mouse model of DMD.
Polish researchers publish new study showing highly positive results with G-CSF treatment for DMD.
This groundbreaking 2015 discovery explains how the understanding of the mechanism of DMD is changing, and how DMD is more closely linked to muscle stem cell missignalling than prior understanding of the disease.
Granulocyte-colony stimulating factor, often given prior to stem cell transplants to mobilize stem cells, is now being studied as a potential low-dose long-term complementary therapy to stem cell therapy.
This flagship study from NeuroGen Brain and Spine Institute, conducted by Dr. Alok Sharma, is perhaps the most extensive stem cell study yet undertaken for Duchenne. Dr. Sharma has since successfully treated over 400 DMD patients with stem cell therapy and is currently conducting another stem cell-DMD clinical trial.
This study examines the potential role stem cell therapy has in healing damaged heart muscles in DMD.
Fetal stem cells are tested for their efficacy in relieving symptoms and damage done by DMD.
Umbilical cord stem cells prove efficacious for DMD.
Muscle stem cells are used for DMD.